{"id":7642,"date":"2025-10-16T23:02:23","date_gmt":"2025-10-16T23:02:23","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/10\/16\/fda-announces-priority-drug-review-vouchers\/"},"modified":"2025-10-16T23:02:23","modified_gmt":"2025-10-16T23:02:23","slug":"fda-announces-priority-drug-review-vouchers","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/10\/16\/fda-announces-priority-drug-review-vouchers\/","title":{"rendered":"STAT+: FDA announces first nine recipients of priority drug review vouchers"},"content":{"rendered":"<p>    STAT+: FDA announces first nine recipients of priority drug review vouchers<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>WASHINGTON \u2014 The Food and Drug Administration on Thursday announced the first nine recipients of the Commissioner\u2019s National Priority Review vouchers, a program offering an expedited drug review to companies with products that align with the agency\u2019s national health priorities.\u00a0<\/p>\n<p>President Trump highlighted one of the recipients, EMD Serono, <a href=\"https:\/\/www.statnews.com\/2025\/10\/16\/trump-ivf-plan-increase-access-fertility-treatment\/\">at a White House news conference<\/a> on expanding access to in vitro fertilization on Thursday. EMD Serono agreed to lower the prices of its existing fertility drugs. In exchange, the company received a voucher for Pergoveris, which stimulates egg development and has already been approved in 74 countries.\u00a0<\/p>\n<p>The other drugs on the list are:\u00a0<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/10\/16\/fda-announces-priority-drug-review-vouchers\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Lizzy Lawrence<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/10\/16\/fda-announces-priority-drug-review-vouchers\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: FDA announces first nine recipients of priority drug review vouchers WASHINGTON \u2014 The Food and Drug Administration on Thursday announced the first nine recipients of the Commissioner\u2019s National Priority Review vouchers, a program offering an expedited drug review to companies with products that align with the agency\u2019s national health priorities.\u00a0 President Trump highlighted one [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4012,2176,2155,2152],"tags":[2150],"class_list":["post-7642","post","type-post","status-publish","format-standard","hentry","category-food-and-drug-administration","category-pharma","category-pharmaceuticals","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7642"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=7642"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7642\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=7642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=7642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=7642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}